QPS Bioanalysis of Small Molecules, Biologics and Cell & Gene Therapy Services
Whether your focus is small molecules, protein biotherapeutics, vaccines, gene therapy, or cell therapy, QPS provides a full range of bioanalytical services to support all of drug development needs from discovery, through clinical development and regulatory filing. Our dedicated, experienced team ensures that drug quantitation studies meet all timelines and regulatory requirements.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Whether your focus is small molecules, protein biotherapeutics, vaccines, gene therapy, or cell therapy, QPS provides a full range of bioanalytical services to support all of drug development needs from discovery, through clinical development and regulatory filing. Our dedicated, experienced team ensures that drug quantitation studies meet all timelines and regulatory requirements.
QPS’ extensive Bioanalysis Department provides high quality data and direct access to our technical experts, who conducts analysis of all small molecules, oligonucleotides, peptides and proteins via LC/MS/MS, while the Translational Medicine Department performs analysis, PK or ADA, of all biologics via ELISA, MSD, RT-qPCR, ddPCR.
In addition, our experts in Genomics are leaders in Gene Expression Translation & Profiling and utilizing Genotyping to accelerate pharmaceutical breakthroughs. Genetic biomarkers are important in the drug development process because they can provide information about the potential risk associated with specific genes. Some examples include ApoE genotyping, which is used to determine patient inclusion/exclusion, and patient stratification in Alzheimer’s disease clinical studies.
